武田やアステラス参入 副作用少ない抗体薬生産 抗がん剤など、５年以内メド 欧米勢を追撃
According to sources, Japanese major phramaceutical companies like Takeda Pharmaceutical Company and Astellas Pharma Inc. will likely begin to produce antibody drugs,which are often used for cancer treatment and others.
In the first step both companies are going to introduce the small-sized producing equipment at factories and laboratories at home for clinical tests. High-quality producing technologies are neede to produce antibody medicin, which has less side effects than conventional drugs and then whose market is expected to expand in the world.
At present it is the case that Japanese companies have gotten far behind from U.S. and European counterparts in developing new antibody medicine. However they intend to catch up with their rivals with their produching know-hows established and to start to mass-produce antibody drugs on a full-fledged basis within five years from now.
According to sources, Japanese major phramaceutical companies like Takeda Pharmaceutical Company and Astellas Pharma Inc. will likely begin to produce antibody drugs,which are often used for cancer treatment and others.
In the first step both companies are going to introduce the small-sized producing equipment at factories and laboratories at home for clinical tests. High-quality producing technologies are neede to produce antibody medicin, which has less side effects than conventional drugs and then whose market is expected to expand in the world.
At present it is the case that Japanese companies have gotten far behind from U.S. and European counterparts in developing new antibody medicine. However they intend to catch up with their rivals with their produching know-hows established and to start to mass-produce antibody drugs on a full-fledged basis within five years from now.
